Lipemia impact on HBA1C measurements in patients with and without hemoglobin variant: a rational laboratory use evaluation.


Journal

Scandinavian journal of clinical and laboratory investigation
ISSN: 1502-7686
Titre abrégé: Scand J Clin Lab Invest
Pays: England
ID NLM: 0404375

Informations de publication

Date de publication:
05 2023
Historique:
medline: 3 5 2023
pubmed: 12 4 2023
entrez: 11 4 2023
Statut: ppublish

Résumé

This study aims to compare the HbA1c test results obtained by widely used methods using samples with various lipemia levels and Hb variants, and to determine whether it is possible to correct the lipemia effect in the identical samples. Out of the laboratory information system (LIS), 48 patients with various HbA1c results were identified including patients with and without Hb variants. After the baseline measurements, all samples were spiked with intralipid solution and treated by a subsequent 0.9% saline replacement procedure. HbA1c values were measured four times sequentially with enzymatic and capillary electrophoresis (CE) methods for each sample, and the measurements were categorized as follows: Baseline; Spiked, 5g/L; Spiked, 20g/L; Post-saline replacement. Sequential HbA1c measurements using the CE method did not show a significant difference, but samples containing 20 g/L triglycerides and samples treated with 0.9% saline replacement showed a significant difference when compared to baseline measurements in both patients with and without Hb variants using the enzymatic method (

Identifiants

pubmed: 37039656
doi: 10.1080/00365513.2023.2198145
doi:

Substances chimiques

Glycated Hemoglobin 0
Saline Solution 0
Hemoglobins, Abnormal 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

194-199

Auteurs

Esra Yıldırım Demirçin (E)

Department of Medical Biochemistry, Ministry of Health, Ankara Bilkent City Hospital, Ankara, Turkey.

Sezen Tutar (S)

Department of Medical Biochemistry, Ministry of Health, Ankara Bilkent City Hospital, Ankara, Turkey.

Sevilay Sezer (S)

Department of Medical Biochemistry, Ministry of Health, Ankara Bilkent City Hospital, Ankara, Turkey.

Filiz Akbıyık (F)

Ankara Bilkent City Hospital Laboratory, Siemens Healthineers, Ankara, Turkey.

Gülsen Yılmaz (G)

Department of Medical Biochemistry, Ministry of Health, Ankara Bilkent City Hospital, Ankara, Turkey.
Department of Medical Biochemistry, Ankara Yıldırım Beyazıt University, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH